We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNA icon
476
Snap-on
SNA
$21.5B
$2M 0.01%
6,929
-254
-4% -$65.8K
PWR icon
477
Quanta Services
PWR
$84.2B
$2M 0.01%
10,157
DVN icon
478
Devon Energy
DVN
$51.3B
$1.95M 0.01%
40,329
-2,287
-5% -$115K
O icon
479
Realty Income
O
$61.1B
$1.95M 0.01%
32,595
-43,321
-57% -$2.64M
VTR icon
480
Ventas
VTR
$47.5B
$1.94M 0.01%
41,144
-34,929
-46% -$1.58M
IBN icon
481
ICICI Bank
IBN
$107B
$1.94M 0.01%
84,000
+56,000
+200% +$1.27M
FORG
482
DELISTED
ForgeRock, Inc.
FORG
$1.94M 0.01%
94,322
-100,812
-52% -$2.02M
XYZ
483
Block Inc
XYZ
$48.9B
$1.94M 0.01%
29,080
-39,828
-58% -$2.49M
CHTR icon
484
Charter Communications
CHTR
$17.3B
$1.92M 0.01%
5,231
-9,209
-64% -$3.14M
EFX icon
485
Equifax
EFX
$22B
$1.9M 0.01%
8,082
-7,877
-49% -$1.66M
WY icon
486
Weyerhaeuser
WY
$17.6B
$1.89M 0.01%
56,403
-47,534
-46% -$1.43M
RNAM
487
DELISTED
Avidity Biosciences
RNAM
$1.89M 0.01%
170,067
CSGP icon
488
CoStar Group
CSGP
$12.2B
$1.87M 0.01%
20,980
-526
-2% -$40.6K
NDAQ icon
489
Nasdaq
NDAQ
$53.4B
$1.85M 0.01%
37,203
-24,589
-40% -$1.33M
NTRS icon
490
Northern Trust
NTRS
$21.8B
$1.84M 0.01%
24,882
-6,197
-20% -$476K
VMC icon
491
Vulcan Materials
VMC
$36.8B
$1.83M 0.01%
8,137
-92
-1% -$17.6K
CPRT icon
492
Copart
CPRT
$28.5B
$1.82M 0.01%
39,994
+3,238
+9% +$134K
TMCI icon
493
Treace Medical Concepts
TMCI
$262M
$1.79M 0.01%
+70,000
New +$1.81M
SJM icon
494
J.M. Smucker
SJM
$13.5B
$1.77M 0.01%
11,997
-1,124
-9% -$171K
BAH icon
495
Booz Allen Hamilton
BAH
$8.44B
$1.76M 0.01%
15,793
GEHC icon
496
GE HealthCare
GEHC
$32.7B
$1.75M 0.01%
21,562
+2,225
+12% +$178K
RF icon
497
Regions Financial
RF
$26.4B
$1.74M 0.01%
97,815
-50,504
-34% -$892K
ACET icon
498
Adicet Bio
ACET
$77.6M
$1.74M 0.01%
44,743
-32,180
-42% -$2.84M
WBA
499
DELISTED
Walgreens Boots Alliance
WBA
$1.74M 0.01%
60,911
-46,698
-43% -$1.52M
CHRW icon
500
C.H. Robinson
CHRW
$20.5B
$1.71M 0.01%
18,159
-4,531
-20% -$438K

Similar funds

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.